Targeting Deficiencies in the TLR5 Mediated Vaginal Response to Treat Female Recurrent Urinary Tract Infection

The identification of the host defence peptides as target effectors in the innate defence of the uro-genital tract creates new translational possibilities for immunomodulatory therapies, specifically vaginal therapies to treat women suffering from rUTI, particularly those carrying the TLR5_C1174T SN...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Ased S. M., Mowbray, Catherine, Lanz, Marcelo, Stanton, Anna, Bowen, Samantha, Varley, Claire L., Hilton, Paul, Brown, Karen, Robson, Wendy, Southgate, Jennifer, Aldridge, Phillip D., Tyson-Capper, Alison, Abraham, Soman, Pickard, Robert S., Hall, Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591273/
https://www.ncbi.nlm.nih.gov/pubmed/28887442
http://dx.doi.org/10.1038/s41598-017-10445-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591273/
https://www.ncbi.nlm.nih.gov/pubmed/28887442
http://dx.doi.org/10.1038/s41598-017-10445-4

Ejemplares similares